Astera Labs, Inc. $ALAB Shares Sold by StoneCrest Wealth Management Inc.

Posted by Francis Steltz on Aug 10th, 2026

StoneCrest Wealth Management Inc. trimmed its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 91.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 584 shares of the company’s stock after selling 6,569 shares during the quarter. StoneCrest Wealth Management Inc.’s holdings in Astera Labs were worth $282,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of ALAB. Reflection Asset Management purchased a new stake in shares of Astera Labs during the 4th quarter valued at $25,000. Smartleaf Asset Management LLC grew its position in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in Astera Labs during the fourth quarter worth about $33,000. Whipplewood Advisors LLC raised its holdings in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after purchasing an additional 319 shares during the period. Finally, Assetmark Inc. raised its holdings in shares of Astera Labs by 78.9% in the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after purchasing an additional 101 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $1,577,250.00. Following the completion of the transaction, the director directly owned 57,466 shares in the company, valued at approximately $25,859,700. This represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the transaction, the director owned 286,863 shares of the company’s stock, valued at $131,492,261.94. This trade represents a 2.87% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,244,395 shares of company stock valued at $358,865,571 over the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

ALAB stock opened at $334.17 on Monday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The firm has a market cap of $57.98 billion, a P/E ratio of 165.43 and a beta of 3.84. The stock has a 50-day simple moving average of $360.45 and a 200-day simple moving average of $235.65.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue was up 104.5% on a year-over-year basis. During the same period last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. TD Cowen decreased their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday. Jefferies Financial Group raised their price target on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday. Barclays lifted their price target on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Finally, Morgan Stanley increased their price objective on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $325.25.

View Our Latest Analysis on ALAB

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.